Pharma News
Last update 23 Oct 2026
#remibrutinib
1 story tagged "remibrutinib".
Advertise Here
Reach qualified buyersBoost your visibility among pharma sourcing professionals and potential buyers.
- Grow your business with qualified leads
- GDS reports on your ad performance
- Targeted to this product's audience
- Direct enquiries from buyers
- Visibility to pharma professionals
Industry News23 Oct 2026
Novartis Pharma AG: Novartis remibrutinib delivered comprehensive disease control in Phase III RMS trials, with proven, robust safety…
Remibrutinib achieved significant and clinically meaningful reduction in relapses vs. teriflunomide, to approximately 1 relapse every 13 years, without the need for chronic B-cell depletion¹?²MRI d...
Finanznachrichten.de•23 Oct 2026
•1 min read
Read story
Latest news
Showing 1–1 of 1 stories
Limited-Time Offer
Advertise on PharmaJungle - Free for 30 Days
Get your company in front of buyers, manufacturers, and sourcing professionals on PharmaJungle - completely free for your first 30 days.
- 30 days of free advertising
- Visibility across all pages
- Performance report with ad insights
- No setup or registration fee
Exclusive introductory offer for new advertisers
Top sources
A
Abnewswire
10 stories
I
Indianpharmapost
5 stories
F
Finanznachrichten.de
5 stories
K
Kalkine Media
4 stories
F
FDA
4 stories
Post your requirement
Get offers from suppliers
- Reach pharmaceutical suppliers
- Specify quality standard and quantity
- Set your shipping preference
- Receive offers directly
- Listed on our marketplace
Your product details and requirements may be published on the marketplace.
Create a New Buying Request
Fields marked with * are mandatory.